Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial
- Eun Young Lee
- , Jae Hyoung Cho
- , Woo Je Lee
- , Nam Hoon Kim
- , Jae Hyeon Kim
- , Byung Wan Lee
- University of Ulsan
- Korea University
- Samsung Medical Center, Sungkyunkwan university
- Yonsei University
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations